Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-14INBX144MANHARD KIMBERLY plan to sell securities of Inhibrx Biosciences, Inc. under Form 144MEDIUM
MANHARD KIMBERLY filed Form 144 to notify SEC of plan to sell 500 units of Inhibrx Biosciences, Inc. securities around 2026-09-14, with aggregate market value of $55,130.00. The total outstanding units is 14717660.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past ...
Small CapBiotechnology
2026-09-14FDMT144David Kirn plan to sell securities of 4D Molecular Therapeutics, Inc. under Form 144MEDIUM
David Kirn filed Form 144 to notify SEC of plan to sell 58333 units of 4D Molecular Therapeutics, Inc. securities around 2026-09-14, with aggregate market value of $802,662.08. The total outstanding units is 55244211.0. The amount planned to be sold represents 0.11% of total outstanding units; Recent transactions in pa...
Small CapBiotechnology